Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ImmunoPrecise Antibodies ...

    NASDAQ: IPA · Real-Time Price · USD
    0.57
    -0.00 (-0.73%)
    At close: May 30, 2025, 3:58 PM
    0.57
    1.05%
    After-hours: May 30, 2025, 07:55 PM EDT
    -0.73%
    Bid 0.54
    Market Cap 26.04M
    Revenue (ttm) 24M
    Net Income (ttm) -46.12M
    EPS (ttm) -1.26
    PE Ratio (ttm) -0.45
    Forward PE -5.23
    Analyst Buy
    Ask 0.58
    Volume 142,493
    Avg. Volume (20D) 1,021,758
    Open 0.57
    Previous Close 0.57
    Day's Range 0.56 - 0.58
    52-Week Range 0.27 - 1.14
    Beta 0.33

    About IPA

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol IPA
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for IPA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    ImmunoPrecise Antibodies Ltd. is scheduled to release its earnings on Jul 28, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    2 months ago
    +11.48%
    ImmunoPrecise Antibodies shares are trading higher... Unlock content with Pro Subscription
    3 months ago
    -3.95%
    ImmunoPrecise Antibodies shares are trading higher after the company announced a collaboration with RIBOPRO.
    news image

    1 week ago · businesswire.com

    ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) a leader in AI-driven biotherapeutics, today announced it has engaged CORE IR, a strategic investor and p...

    news image

    1 week ago · businesswire.com

    ImmunoPrecise Antibodies (IPA) to Present at Maxim Group's 2025 Virtual Tech Conference

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) a leader in AI-driven biotherapeutics, today announced that Dr. Jennifer Bath, CEO of ImmunoPrecise Antib...

    news image

    2 weeks ago · businesswire.com

    IPA's LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed

    AUSTIN, Texas--(BUSINESS WIRE)---- $AMD #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics, is pleased to announce today new benchmarking results that validate...

    news image

    3 weeks ago · businesswire.com

    Fujifilm Invites Entries for its Innovation Print Awards Contest

    HANOVER PARK, Ill.--(BUSINESS WIRE)--FUJIFILM North America Corporation, Business Innovation Division, has announced a call for entries to Fujifilm's global Innovation Print Awards (IPA) contest. The ...

    news image

    1 month ago · businesswire.com

    ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) a leader in AI-driven biotherapeutics, today announced its strong support for the U.S. Food and Drug Admi...

    news image

    2 months ago · zacks.com

    ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock?

    ImmunoPrecise Antibodies (IPA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    news image

    2 months ago · seekingalpha.com

    ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call Transcript

    ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q3 2025 Earnings Conference Call March 28, 2025 10:30 AM ET Company Participants Jennifer Bath - Chief Executive Officer and President Joseph Scheffler - In...

    news image

    2 months ago · zacks.com

    ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates

    ImmunoPrecise Antibodies Ltd. (IPA) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate.

    news image

    2 months ago · businesswire.com

    ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today reported financial...

    news image

    2 months ago · businesswire.com

    ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) is pleased to announce a strategic partnership with a leading biotechnology company with a multi-billion-...

    Add to Watchlist